Abstract. In the context of personalized medicine, text mining methods pose an interesting option for identifying disease-gene associations, as they can be used to generate novel links between diseases and genes which may complement knowledge from structured databases. The most straightforward approach to extract such links from text is to rely on a simple assumption postulating an association between all genes and diseases that co-occur within the same document. However, this approach (i) tends to yield a number of spurious associations, (ii) does not capture different relevant types of associations, and (iii) is incapable of aggregating knowledge that is spread across documents. Thus, we propose an approach in which disease-gene co-occurrences and gene-gene interactions are represented in an RDF graph. A machine learning-based classifier is trained that incorporates features extracted from the graph to separate disease-gene pairs into valid disease-gene associations and spurious ones. On the manually curated Genetic Testing Registry, our approach yields a 30 points increase in F1 score over a plain co-occurrence baseline.
Introduction
Most current approaches in personalized medicine, irrespective of particular treatment modalities (e.g., small molecules, biologics, novel approaches like gene therapy), are centered around modulating a gene in order to modulate aspects of a disease [10] . Therefore, the detection of disease-gene links is an important starting point in drug discovery.
Text mining methods pose an interesting option for identifying disease-gene links, as they can be used to generate new target (and therefore treatment) hypotheses and, in combination with experimental data, support the prioritization of research aimed at the discovery of new drug targets. Until now, text mining methods for disease-gene associations mostly rely on the degree of textual co-occurrence [19] . While those approaches are largely reliable in detecting wellknown links for well-known diseases [1, 5, 18] , such well-known links are of minor interest in drug research, as they do not support the discovery of new targets. Such novel targets are difficult to detect, as they often require the aggregation of evidence across individual documents; at the same time, they potentially shed light on yet unknown disease-gene links.
In this paper, we propose a classification model for predicting novel diseasegene associations from biomedical text. The model combines private (intradocument) as well as public (cross-document) knowledge as defined by Swanson et al. [21] in terms of features based on local co-occurrences within documents and relations between diseases and genes that have been aggregated across individual documents. In an evaluation against an existing database, we address the following research questions: (i) Can such a combined model outperform a purely co-occurrence-based approach? (ii) What is the impact of features measuring the connectivity of diseases and genes? (iii) What is the impact of graph-based features capturing interactions between genes across documents?
2 System Architecture Our system architecture consists of the following components (cf. Fig. 1 ):
1. Medline Corpus: All analyses are done on Medline 4 , comprising a total of 21.5M abstracts. 2. Information Extraction: We rely on existing information extraction systems to identify disease names, genes/proteins and interactions between them. For disease recognition, we use a state-of-the-art CRF tagger [11] that has been trained on the NCBI Disease Corpus [7] . Using the normalization procedure described in [22] , disease names are reduced to a vocabulary of approx. 15K unique identifiers extracted from MeSH 5 and OMIM 6 . For the identification of genes/proteins and their interactions, we rely on TEES [3] , a state-of-the-art event extraction system that has been tailored to the detection of molecular interactions from biomedical text. All extracted genes are normalized using GeNo [24] and afterwards filtered by human genes using taxonomic information from EntrezGene [14] . 
Postprocessing:
The complexity of the interaction graphs produced by TEES (see Fig. 2 ) is incrementally reduced. Fig. 3 gives a running example of the individual steps described in the following:
(a) RDFication: TEES graphs are broken down into binary relations by selecting all shortest paths that connect two proteins with respect to their semantic relation. These are represented as one RDF triple connecting two proteins. The path between the two proteins is serialized as a string and used as the name of an RDF property connecting both proteins. (b) Simplification: Semantic role information (i.e., cause and theme) is omitted. The direction of interactions is still captured in the directed edges of the graph. (c) Generalization: The TEES extraction scheme, originally consisting of 9 relations, was reduced to five relations after discussion with a domain expert: Expression, Catabolism, Localization, Binding and Regulation. as well, we join paths connecting two genes up to a distance of two edges. The join of the paths is serialized again, the above post-processing steps are applied and the results are stored as RDF triples. We refer to such serialized paths as path signatures. 
Database:
The results of all the steps described above are stored in an RDF database, Blazegraph 7 . 5. Gene Classification System: Given a disease as input, protein candidates are classified as to whether or not they interact with that disease. The classifier relies on features extracted for each pair of disease and protein. Being our main contribution, this component is described in the next section.
Gene Classification System
Our gene classification system takes a disease as input and predicts, for each gene in the database, whether it interacts with the given disease or not. The classifier is implemented as a Support Vector Machine relying on features that are extracted for each disease-gene pair. Seven feature groups are defined in total, which can be divided into co-occurrence-based (CBF) and graph-based (GBF) features, as described below. Our notation is as follows: Let D be the set of all diseases and G the set of all genes in the database 8 and P a vocabulary of predicates denoting semantic relations between them. Then, T denotes the set of all triples in the database, such that:
Co-occurrence-based Features
CBF features are based on the co-occurrence between diseases and genes. We consider T d ⊂ T = { d , coocc, g |d = d}, the set of all genes co-occurring with a particular disease d, and analogously
, g = g} denotes the set of all co-occurrences of a particular disease d and a particular gene g.
Entropy.
We compute the entropy H(g) of a gene g in order to measure the specificity of g in terms of the diseases it co-occurs with. If g co-occurs with only a few specific diseases, this results in low entropy and high specificity. Co-occurrence with many diseases yields high entropy and low specificity. We compute the entropy of g as
Analogously, we compute the entropy/specificity H(d) of a disease d in terms of the genes it co-occurs with.
Co-occurrence Frequencies. This feature group combines relative co-occurrence frequencies of a disease-gene pair (d, g):
Besides the normalization given in Equation (1) Grades. This feature group consists of two features which capture a normalized frequency of triples that contain d or g, respectively:
Odds Ratio is used to assess the degree of association between d and g:
The higher Odds(d, g), the stronger the association between d and g. Odds(d, g) =  can only be achieved if |T dg | = 0.
TF-IDF. In order to assess the relevance of a gene g for a disease d, we apply the tf idf metric from information retrieval which takes term frequency (tf ) and inverted document frequency (idf ) into account [15] :
Considering a disease as a "bag of genes", tf (d, g) is equivalent to |T dg |, while idf (g) can be computed in terms of Equation (3):
High values of tf idf (d, g) indicate that g is mentioned frequently in the context of d, but still sufficiently specific to be informative for d, which we expect to be indicative of a relevant association between d and g.
Graph-based Features
In contrast to the previously described feature groups which take a disease and a gene into account, GBF features are calculated independently of a particular disease in that they are entirely based on the gene interaction graph, i.e., the set of triples I ⊂ T = { g, interact, g |g, g ∈ G}.
Path Signatures. Each gene g is described in terms of a "bag of (outgoing) path signatures", S out (g) ⊂ I = { g , interact, g |g = g }, which have been constructed by joining individual edges in the gene interaction network (cf. Section 2, postprocessing step (3e)). We use interact as a placeholder for all predicates constructed in this process. The strength of interaction between a pair g, g ∈ S out (g) is weighted by the tf idf metric, expressing tf (g, g ) and idf (g ) analogously to the definitions in Section 3.1 (cf. Equation (3)). Path signatures encoding an important relation between g and g in terms of a high tf idf value are considered useful for predicting novel disease-gene associations in cases where no direct evidence from co-occurrence relations is available yet.
Gene Connectivity. This feature group describes the connectivity of a gene within the graph. Analogously to S out (g) above, we define S in (g, l) and S out (g, l) as lists of all incoming and outgoing signatures of path length l, respectively. Further, L denotes the maximum path length. Based on these definitions, we count the number of incoming and outgoing signatures for each path length 1 ≤ l ≤ L separately, as given in (4), and by accumulation over all path lengths. In these features, higher values indicate a higher connectivity of g in the network.
We also measure the ratio of outgoing and incoming signatures per gene in terms of IORatio(g) = |S out (g)|/|S in (g)|. If IORatio(g) > , g has a manipulating role in the network; otherwise, g tends to be manipulated by other genes.
Experimental Evaluation

Experimental Settings
Gold Standard. The Genetic Testing Registry (GTR; [20] ) is a manually curated database for results from biomedical experiments, mostly at the intersection of Mendelian disorders and human genes. Our GTR dump contains 5,800 diseasegene associations built from 4,200 diseases and 2,800 genes. Experimental Procedure. We train an SVM classifier using an RBF kernel [6] and apply grid search for meta-parameter optimization based on the LibSVM 9 and WEKA 10 toolkits. The trained model is applied to the task of predicting genes that are associated with a given disease. We evaluate the model on the GTR test set described above, reporting precision, recall and F 1 score. Evaluation results are reported in Table 1 . The left part displays classification performance of individudal feature groups; in the right part, testing performance of feature combinations (as selected by cross-validation on the training data) are shown. The baseline refers to the performance of a single-feature classifier relying on co-occurrence counts as described in Equation (1).
Results and Discussion
The results clearly indicate a positive impact of both cooccurrence-based and graph-based features, as all feature combinations yield an increase over the baseline in both precision and recall. The CBF combination achieves highest overall precision, whereas connectivity and signature features improve recall (at the expense of slight losses in precision). As for path signatures, it is most effective to select only a small number of individual paths. We determine the best 50 path signature features based on information gain [12] . In the best-performing configuration (CBF+Conn+Best50Sig), our system outperforms the co-occurrence baseline by 1.7 points in precision and 43.4 points in recall.
Increasing the recall relative to the co-occurrence baseline is a key prerequisite towards our goal of discovering novel disease-gene associations. Given that the GTR gold standard is relatively small and slightly biased towards Mendelian disorders, we subject the best-performing model to another evaluation in a practical use case, as described in the next section. In this experiment, our classification model was applied to the entire Medline corpus in order to predict genes related to pulmonary fibrosis (PF). The resulting hits were sorted by their corpus frequency and the 200 most frequent candidates were manually evaluated by a biomedical expert (who is not a PF researcher, though). Table 2 shows the preliminary results of this analysis: 38.5% of the predictions are unanimously correct, whereas only 22% are clear errors. The missing mass is due to candidates for which hints were found that the gene may be associated with PF through relevant mechanisms or pathways. Thus, these candidates constitute plausible hypotheses which need further investigation by a PF expert. Main sources of erroneous predictions are false co-occurrences (e.g., due to negation contexts) or false positives as produced by the gene recognition component. Some errors of the latter type may be eliminated by incorporating the filtering approach proposed by [9] . In sum, this analysis clearly shows that our system is capable of generating promising candidates worth further investigation.
Related Work
Three types of approaches have been proposed to tackle the problem of extracting explicitly mentioned disease-associated genes (DAGs) but also generating novel hypotheses from scientific publications. First, several authors extract DAGs from existing biomedical databases such as GeneSeeker [8] or PolySearch [4] . Piñero et al. developed DisGeNET [17] , a database quantifying the degree of disease-gene associations by a combination of different sources of evidence, with textual cooccurrence being one of the main sources. Obviously, these approaches lack the ability to discover new target hypotheses. Second, text mining techniques have been considered as an alternative and are mostly based on textual co-occurrence (sentence or document-based). Such systems can be optimized on precision [5] or recall [18] . Al-Mubaid presents a technique using various information-theoretic concepts to support the co-occurrence-based extraction [1] . Third, a promising alternative to overcome mere textual co-occurrence is to aggregate knowledge across single publications (cf. [23] ) into larger interaction graphs, as we also do in our approach. Nevertheless, the knowledge extraction to build those interaction graphs often relies on text mining techniques and natural language processing methods as in the BITOLA system [2] or in the approaches of Wren et al. [26] and Wilkinson et al. [25] . Closely related to our approach is the one byÖzgür et al. [16] who extract interaction paths from dependency networks and rely on graph centrality measures to rank proteins for a given disease. Contrary to our model, they do not use complex features extracted from the graph and do not combine different types of features.
Conclusions and Outlook
In this paper, we have presented a system and a model for predicting diseasegene associations from biomedical text, using a combination of features based on disease-gene co-occurrences and gene interactions that are represented in a graph database. In a classification experiment against a manually curated database used as gold standard, we were able to demonstrate the effectiveness of both types of features, outperforming a plain co-occurrence baseline by more than 30 points in F 1 score. Moreover, preliminary investigation of a practical use case from pharmaceutical industry suggests that almost 80% of the candidates predicted by our model are plausible and may support pharmaceutical researchers in hypothesis generation. In future work, we will carry out a more detailed evaluation of the case study and supplement our classification approach by a ranking model that not only separates positive and negative candidates but also reflects relative differences in these candidates' plausibility.
